Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $2.47 billion
- Book Value:
- Revenue TTM:
- $1.24 billion
- Operating Margin TTM:
- Gross Profit TTM:
- $596.71 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Omnicell Inc had its IPO on 2001-08-07 under the ticker symbol OMCL.
The company operates in the Healthcare sector and Health Information Services industry. Omnicell Inc has a staff strength of 3,780 employees.
Shares of Omnicell Inc opened at $54.55 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $53.02 - $55.11, and closed at $53.42.
This is a -2.29% slip from the previous day's closing price.
A total volume of 508,890 shares were traded at the close of the day’s session.
In the last one week, shares of Omnicell Inc have slipped by -6.35%.
Omnicell Inc's Key Ratios
Omnicell Inc has a market cap of $2.47 billion, indicating a price to book ratio of 1.8695 and a price to sales ratio of 1.6519.
In the last 12-months Omnicell Inc’s revenue was $1.24 billion with a gross profit of $596.71 million and an EBITDA of $36.29 million. The EBITDA ratio measures Omnicell Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Omnicell Inc’s operating margin was -1.79% while its return on assets stood at -0.64% with a return of equity of -2.06%.
In Q2, Omnicell Inc’s quarterly earnings growth was a negative -61.8% while revenue growth was a negative 9.8%.
Omnicell Inc’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $-0.5 per share while it has a forward price to earnings multiple of 29.4985 and a PEG multiple of 2.28. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Omnicell Inc’s profitability.
Omnicell Inc stock is trading at a EV to sales ratio of 1.8804 and a EV to EBITDA ratio of 16.9556. Its price to sales ratio in the trailing 12-months stood at 1.6519.
Omnicell Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $2.19 billion
- Total Liabilities
- $370.16 million
- Operating Cash Flow
- Capital Expenditure
- $14.82 million
- Dividend Payout Ratio
Omnicell Inc ended 2023 with $2.19 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $2.19 billion while shareholder equity stood at $1.16 billion.
Omnicell Inc ended 2023 with $1.51 million in deferred long-term liabilities, $370.16 million in other current liabilities, 56000.00 in common stock, $379.18 million in retained earnings and $735.52 million in goodwill. Its cash balance stood at $399.46 million and cash and short-term investments were $399.46 million. The company’s total short-term debt was $10,951,000 while long-term debt stood at $568.11 million.
Omnicell Inc’s total current assets stands at $881.36 million while long-term investments were $35.04 million and short-term investments were $11.08 million. Its net receivables were $273.90 million compared to accounts payable of $47.19 million and inventory worth $130.58 million.
In 2023, Omnicell Inc's operating cash flow was $-14817000.00 while its capital expenditure stood at $14.82 million.
Comparatively, Omnicell Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Omnicell Inc stock is currently trading at $53.42 per share. It touched a 52-week high of $98.64 and a 52-week low of $98.64. Analysts tracking the stock have a 12-month average target price of $72.13.
Its 50-day moving average was $63.21 and 200-day moving average was $60.18 The short ratio stood at 4.45 indicating a short percent outstanding of 0%.
Around 155.5% of the company’s stock are held by insiders while 10283.2% are held by institutions.
Frequently Asked Questions About Omnicell Inc
Similar Industry Stocks (Health Information Services)
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility’s in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Santa Clara, California.